Ascending Dose Tolerability Trial and PK Assessment in Healthy Volunteers After Single & Multiple Oral Intake of DF2755A
Stopped The Sponsor decided to not proceed from SAD to MAD to explore the possibility of further studying PD.
Conditions
Interventions
- DRUG: DF2755A
- OTHER: Placebo
Sponsor
Dompé Farmaceutici S.p.A